Meet the Volume Editor

Dr. Erman Salih Istifli's postdoctoral studies include the discovery of candidate phytochemicals in the treatment of SARS-CoV-2, DNA–ligand interactions, and the discovery of plant-based natural inhibitors against certain enzymes (AChE, BChE, alpha-amylase, alpha-glucosidase, and tyrosinase) that are important regulators of human health. He has been the scientific editor of the *International Journal of Plant Based Pharmaceuticals* since 2021.

## Contents


### **Chapter 6 119**

Repurposing Drugs as Potential Therapeutics for the SARS-Cov-2 Viral Infection: Automatizing a Blind Molecular Docking High-throughput Pipeline *by Aldo Herrera-Rodulfo, Mariana Andrade-Medina and Mauricio Carrillo-Tripp*

#### **Chapter 7 149**

N1-(3-(Trifluoromethyl)Phenyl) Isophthalamide Derivatives as Promising Inhibitors of Vascular Endothelial Growth Factor Receptor: Pharmacophore-Based Design, Docking, and MM-PBSA/MM-GBSA Binding Energy Estimation *by Aliaksandr Faryna and Elena Kalinichenko*
